US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 20, 2021 (5 years ago)

Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03

Recalling firm
American Health Packaging
NDC code
68001-501-03
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0451-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Metoprolol recalls

See all